0
ARTICLE |

Treatment of Traveler's Diarrhea With Sulfamethoxazole and Trimethoprim and Loperamide FREE

Charles D. Ericsson, MD; Herbert L. DuPont, MD; John J. Mathewson, PhD; M. Stewart West, PhD; Philip C. Johnson, MD; Jo Ann M. Bitsura, MPH
[+] Author Affiliations

Presented at the Annual Meeting of the American Federation of Clinical Research, Washington, DC, April 28,1988.

Reprint requests to Division of Infectious Diseases, Department of Medicine, University of Texas Medical School at Houston, 6431 Fannin St, Room 1.728, Houston, TX 77030 (Dr Ericsson).


JAMA. 1990;263(2):257-261. doi:10.1001/jama.1990.03440020091039
Text Size: A A A
Published online

In a randomized, double-blind, placebo-controlled trial, 227 US adults with acute diarrhea in Mexico received a single dose of sulfamethoxazole and trimethoprim (1600/320 mg) or 3 days of therapy with loperamide hydrochloride (4-mg loading dose, then 2 mg orally after each loose stool), sulfamethoxazole-trimethoprim (800/160 mg orally twice daily), or the combination of both. Subjects treated with the combination had the shortest average duration of diarrhea compared with the placebo group (1 hour vs 59 hours), took the least amount of loperamide after the loading dose (3.8 mg), and had the shortest duration of diarrhea associated with fecal leukocytes or blood-tinged stools (4.5 hours). A single dose of sulfamethoxazole-trimethoprim was also efficacious (28 vs 59 hours), but loperamide alone was significantly effective only when treatment failures were treated with antibiotics (33 vs 58 hours). The combination of sulfamethoxazole-trimethoprim plus loperamide can be highly recommended for the treatment of most patients with travelers diarrhea.

(JAMA. 1990;263:257-261)

REFERENCES

Ericsson CD, DuPont HL.  Travelers' diarrhea: recent developments . In: Remington JS, Swartz MN, eds. Current Clinical Topics in Infectious Diseases . New York, NY: McGraw-Hill International Book Co; 1985;;6:66-84.
 Travelers' diarrhea . JAMA . 1985;;253:2700-2704. Consensus Conference.
Ericsson CD, DuPont HL.  Antimicrobial agents in the management of travelers' diarrhea . In: Peterson PK, Verhoef J, eds. The Antimicrobial Agents Annual . Amsterdam, the Netherlands: Elsevier Science Publishers; 1988;;3:541-551.
Ericsson CD, DuPont HL, Johnson PC.  Nonantibiotic therapy for travelers' diarrhea . Rev Infect Dis. 1986;;8( (suppl 2) ):S202-S204.
Johnson PC, Ericsson CD, DuPont HL, Morgan DR, Bitsura JAM, Wood LV.  Comparison of loper-amide with bismuth subsalicylate for the treatment of acute travelers' diarrhea . JAMA . 1986;;255:757-760.
Ericsson CD, Johnson PC, DuPont HL, Morgan DR.  Role of a novel antimicrobial agent, BW942C, used alone or in combination with trimethoprim/ sulfamethoxazole in the treatment of travelers' diarrhea . Antimicrob Agents Chemother. 1986;; 29:1040-1046.
Pickering LK, DuPont HL, Olarte J.  Single-dose tetracycline for shigellosis in adults . JAMA . 1978;;239:853-854.
Oldfield EC III, Bourgeois AL, Omar A-KM, Pazzaghia GL.  Empirical treatment of Shigella dysentery with trimethoprim: five-day course vs single dose . Am J Trop Med Hyg. 1987;;37:616-623.
Goutuzzo E, Oberhelman RA, Maguina C, et al.  Comparison of single-dose treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults . Antimicrob Agents Chemother. 1989;; 33:1101-1104.
Mathewson JJ, Oberhelman RA, DuPont HL, de la Cabada FJ, Garibay EV.  Enteroadherent Escherichia coli as a cause of diarrhea among children in Mexico . J Clin Microbiol. 1987;;25:1917-1919.
Murray BE, Mathewson JJ, DuPont HL, Hill WE.  Utility of oligodesoxyribonucleotide probes for detecting enterotoxigenic Escherichia coli . J Infect Dis. 1987;;155:809-811.
Ericsson CD, Johnson PC, DuPont HL, Morgan DR, Bitsura JAM, de la Cabada PJ.  Ciprofloxacin or trimethoprim/sulfamethoxazole as initial therapy for travelers' diarrhea . Ann Intern Med. 1987;;106:216-220.
Ericsson CD, DuPont HL, Sullivan P, Galindo E, Evans DG, Evans DJ Jr.  Bicozamycin, a poorly absorbable antibiotic, effectively treats travelers' diarrhea . Ann Intern Med. 1983;;98:20-25.
Anderson S, Auquier A, Hauck WW, Oakes D, Vandaele W, Weisberg HI. Statistical Methods for Comparative Studies . New York, NY: John Wiley & Sons Inc; 1980;.
 Drop-outs from clinical trials . Lancet . 1987;; 2:892-893. Editorial.
Zimmer WJ, Brown JT, Linzer M.  Randomization in clinical trials . Ann Intern Med. 1987;; 107:790.
Ericsson CD, Patterson TF, DuPont HL.  Clinical presentation as a guide to therapy for travelers' diarrhea . Am J Med Sci. 1987;;30:91-96.
DuPont HL, Hornick RB.  Adverse effect of Lomotil therapy in shigellosis . JAMA . 1973;; 226:1525-1528.
Parsonnet J, Greene KD, Gerber AR, Tauxe RV, Vallejo Aguilar OJ, Blake PA.  Shigella dysenteriae type 1 infections in U.S. travellers to Mexico, 1988 . Lancet . 1989;;2:543-545.
Butler T, Islam MR, Azad MAK, Jones PK.  Risk factors for development of hemolytic uremic syndrome during shigellosis . J Pediatr. 1987;; 110:894-897.
Taylor N, Houston R, Shlim DR, Bhaibulaya M, Ungar BLP, Echeverria P.  Etiology of diarrhea among travelers and foreign residents in Nepal . JAMA . 1988;;260:1245-1248.
Farrar WE.  Antibiotic resistance in developing countries . J Infect Dis. 1985;;152:1103-1106.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Ericsson CD, DuPont HL.  Travelers' diarrhea: recent developments . In: Remington JS, Swartz MN, eds. Current Clinical Topics in Infectious Diseases . New York, NY: McGraw-Hill International Book Co; 1985;;6:66-84.
 Travelers' diarrhea . JAMA . 1985;;253:2700-2704. Consensus Conference.
Ericsson CD, DuPont HL.  Antimicrobial agents in the management of travelers' diarrhea . In: Peterson PK, Verhoef J, eds. The Antimicrobial Agents Annual . Amsterdam, the Netherlands: Elsevier Science Publishers; 1988;;3:541-551.
Ericsson CD, DuPont HL, Johnson PC.  Nonantibiotic therapy for travelers' diarrhea . Rev Infect Dis. 1986;;8( (suppl 2) ):S202-S204.
Johnson PC, Ericsson CD, DuPont HL, Morgan DR, Bitsura JAM, Wood LV.  Comparison of loper-amide with bismuth subsalicylate for the treatment of acute travelers' diarrhea . JAMA . 1986;;255:757-760.
Ericsson CD, Johnson PC, DuPont HL, Morgan DR.  Role of a novel antimicrobial agent, BW942C, used alone or in combination with trimethoprim/ sulfamethoxazole in the treatment of travelers' diarrhea . Antimicrob Agents Chemother. 1986;; 29:1040-1046.
Pickering LK, DuPont HL, Olarte J.  Single-dose tetracycline for shigellosis in adults . JAMA . 1978;;239:853-854.
Oldfield EC III, Bourgeois AL, Omar A-KM, Pazzaghia GL.  Empirical treatment of Shigella dysentery with trimethoprim: five-day course vs single dose . Am J Trop Med Hyg. 1987;;37:616-623.
Goutuzzo E, Oberhelman RA, Maguina C, et al.  Comparison of single-dose treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults . Antimicrob Agents Chemother. 1989;; 33:1101-1104.
Mathewson JJ, Oberhelman RA, DuPont HL, de la Cabada FJ, Garibay EV.  Enteroadherent Escherichia coli as a cause of diarrhea among children in Mexico . J Clin Microbiol. 1987;;25:1917-1919.
Murray BE, Mathewson JJ, DuPont HL, Hill WE.  Utility of oligodesoxyribonucleotide probes for detecting enterotoxigenic Escherichia coli . J Infect Dis. 1987;;155:809-811.
Ericsson CD, Johnson PC, DuPont HL, Morgan DR, Bitsura JAM, de la Cabada PJ.  Ciprofloxacin or trimethoprim/sulfamethoxazole as initial therapy for travelers' diarrhea . Ann Intern Med. 1987;;106:216-220.
Ericsson CD, DuPont HL, Sullivan P, Galindo E, Evans DG, Evans DJ Jr.  Bicozamycin, a poorly absorbable antibiotic, effectively treats travelers' diarrhea . Ann Intern Med. 1983;;98:20-25.
Anderson S, Auquier A, Hauck WW, Oakes D, Vandaele W, Weisberg HI. Statistical Methods for Comparative Studies . New York, NY: John Wiley & Sons Inc; 1980;.
 Drop-outs from clinical trials . Lancet . 1987;; 2:892-893. Editorial.
Zimmer WJ, Brown JT, Linzer M.  Randomization in clinical trials . Ann Intern Med. 1987;; 107:790.
Ericsson CD, Patterson TF, DuPont HL.  Clinical presentation as a guide to therapy for travelers' diarrhea . Am J Med Sci. 1987;;30:91-96.
DuPont HL, Hornick RB.  Adverse effect of Lomotil therapy in shigellosis . JAMA . 1973;; 226:1525-1528.
Parsonnet J, Greene KD, Gerber AR, Tauxe RV, Vallejo Aguilar OJ, Blake PA.  Shigella dysenteriae type 1 infections in U.S. travellers to Mexico, 1988 . Lancet . 1989;;2:543-545.
Butler T, Islam MR, Azad MAK, Jones PK.  Risk factors for development of hemolytic uremic syndrome during shigellosis . J Pediatr. 1987;; 110:894-897.
Taylor N, Houston R, Shlim DR, Bhaibulaya M, Ungar BLP, Echeverria P.  Etiology of diarrhea among travelers and foreign residents in Nepal . JAMA . 1988;;260:1245-1248.
Farrar WE.  Antibiotic resistance in developing countries . J Infect Dis. 1985;;152:1103-1106.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.